US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist
  • 122.970
  • -1.630-1.31%
Close Dec 30 16:00 ET
  • 122.970
  • 0.0000.00%
Post 20:01 ET
7.43BMarket Cap17.42P/E (TTM)

About Jazz Pharmaceuticals Company

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Company Profile

SymbolJAZZ
Company NameJazz Pharmaceuticals
Listing DateJun 1, 2007
Issue Price18.00
Founded2005
CEOMr. Bruce C. Cozadd
MarketNASDAQ
Employees2800
Fiscal Year Ends12-31
AddressWaterloo Exchange,Waterloo Road,5th Floor
CityDublin
ProvinceDublin
CountryIreland
Zip Code4
Phone353-1-634-7800
Websitehttp://www.jazzpharmaceuticals.com

Company Executives

  • Name
  • Position
  • Salary
  • Bruce C. Cozadd
  • Chairman of the Board and Chief Executive Officer
  • 15.34M
  • Neena M. Patil
  • Executive Vice President and Chief Legal Officer
  • 3.88M
  • Patricia Carr
  • Senior Vice President and Chief Accounting Officer
  • 1.40M
  • Philip L. Johnson
  • Executive Vice President and Chief Financial Officer
  • --
  • Renee D. Gala
  • President and Chief Operating Officer
  • 5.43M
  • Liz Henderson
  • Senior Vice President, Technical Operations
  • --
  • Samantha Pearce
  • Senior Vice President, Europe and International
  • --
  • Dr. Robert Iannone, M.D.
  • Executive Vice President and Global Head of Research and Development
  • 4.98M
  • Anne O'Riordan
  • Independent Director
  • 523.77K
  • Seamus C. Mulligan
  • Independent Director
  • 531.27K
  • Jennifer E. Cook
  • Independent Director
  • 533.77K
  • Heather Ann McSharry
  • Independent Director
  • 543.77K
  • Patrick Thomas Kennedy
  • Independent Director
  • --
  • Rick E. Winningham
  • Lead Independent Director
  • 571.27K
  • Dr. Mark D. Smith, M.D.
  • Independent Director
  • 521.27K
  • Kenneth W. O'Keefe
  • Independent Director
  • 513.77K
  • Laura J. Hamill
  • Independent Director
  • --
  • Dr. Norbert G. Riedel,PhD
  • Independent Director
  • 533.77K
  • Patrick G. Enright, M.B.A.
  • Independent Director
  • 526.27K
Heat List
US
Overall
Symbol
Price
% Chg

No Data